Sy, Eduardo C.

HRN: 21-46-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2022
06/27/2022
IV
600mg
Q8H
Gangrenous Wound
Waiting Final Action 
06/21/2022
CEFTAZIDIME 1GM (VIAL)
06/21/2022
06/27/2022
IV
1g
Q8
Infected Wound Left Foot
Waiting Final Action 
06/26/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/26/2022
06/26/2022
IV
4.5gm
As LD Now
CBC
Waiting Final Action 
06/26/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/26/2022
07/03/2022
IV
2.25gm
Q8
CBC
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: